The biological activities, molecular docking studies, and anticancer effects of 1-arylsuphonylpyrazole derivatives

dc.contributor.authorTaslimi, Parham
dc.contributor.authorErden, Yavuz
dc.contributor.authorMamedov, Sabir
dc.contributor.authorZeynalova, Lala
dc.contributor.authorLadokhina, Nina
dc.contributor.authorTaş, Recep
dc.contributor.authorTuzun, Burak
dc.contributor.authorErden, Yavuz
dc.contributor.authorTaş, Recep
dc.contributor.authorTaslimi, Parham
dc.date.accessioned2025-10-18T13:24:18Z
dc.date.created2020
dc.date.issued2020
dc.departmentFakülteler, Fen Fakültesi, Biyoteknoloji Bölümü
dc.departmentFakülteler, Fen Fakültesi, Moleküler Biyoloji ve Genetik Bölümü
dc.description.abstractThis work is devoted to definition of the direction of reaction between 1-benzenesulfonylimino pyridinium chloride and alpha- or beta-halo-containing sulfamides, chloroacetic acid, 1-chloro-2,3-dihydroxypropane, etc. The optimal conditions for the synchronous reaction of heterocyclization are determined. Benzenesulfonyliminopyridinium chloride was obtained to form pyrazolopyridines with 1,2-polarophiles, and pyridazine pyridines with 1,3-polarophiles. These novel derivatives were found as effective inhibitors of the alpha-glycosidase with K-i values in the range of 13.66 +/- 2.63-60.63 +/- 12.71 nM. The molecules (II-X) against enzyme were compared theoretically with the help of molecular docking to compare biological activities. The results were compared with the numerical values of the parameters obtained from molecular docking calculations and found to be in great agreement with the experimental results. However, ADME analysis of molecules was performed. Also, the compounds exhibited significant anticancer effect depending on the doses administered. Communicated by Ramaswamy H. Sarma
dc.description.sponsorshipScientific Research Project Fund of Sivas Cumhuriyet University [RGD-020]; King Saud University, Saudi Arabia [RSP-2019/59]
dc.description.sponsorshipThis work is supported by the Scientific Research Project Fund of Sivas Cumhuriyet University under the project number RGD-020. This research was made possible by TUBITAK ULAKBIM, High Performance and Grid Computing Center (TR-Grid e-Infrastructure). Also, S.A would like to extend his sincere appreciation to the Researchers Supporting Project (RSP-2019/59), King Saud University, Saudi Arabia.
dc.identifier.doi10.1080/07391102.2020.1763838
dc.identifier.endpage3346
dc.identifier.issn0739-1102
dc.identifier.issn1538-0254
dc.identifier.issue9
dc.identifier.orcidAsgarova, Kamala/0009-0007-7771-7594
dc.identifier.orcidSadeghian, nastaran/0009-0004-2966-9231
dc.identifier.orcidTas, Recep/0000-0002-3743-7770
dc.identifier.orcidTUZUN, BURAK/0000-0002-0420-2043
dc.identifier.orcidErden, Yavuz/0000-0002-2807-6096
dc.identifier.orcidSucayev, Afsun/0000-0002-4135-9568
dc.identifier.orcidTaslimi, Parham/0000-0002-3171-0633
dc.identifier.pmid32364008
dc.identifier.scopus2-s2.0-85084976262
dc.identifier.scopusqualityQ2
dc.identifier.startpage3336
dc.identifier.urihttps://doi.org/10.1080/07391102.2020.1763838
dc.identifier.urihttps://hdl.handle.net/11772/22880
dc.identifier.volume39
dc.identifier.wosWOS:000534936300001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Inc
dc.relation.ispartofJournal of Biomolecular Structure & Dynamics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.relation.sdgGoal-03: Good Health and Well-Being
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzWoS_20251016
dc.subjectPyrazolpiridines
dc.subjectPyridazole Pyridines
dc.subjectAnticancer
dc.subjectEnzyme Inhibition
dc.subjectMolecular Docking
dc.titleThe biological activities, molecular docking studies, and anticancer effects of 1-arylsuphonylpyrazole derivatives
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublication03e83980-c1b3-4acd-94a9-b6bc0b0a5695
relation.isAuthorOfPublicationad45cdc7-0a6c-4baa-bd22-c048e5f7169a
relation.isAuthorOfPublicationdadfa319-65b8-4543-92b4-bea49e0139e9
relation.isAuthorOfPublication.latestForDiscovery03e83980-c1b3-4acd-94a9-b6bc0b0a5695

Dosyalar